Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1‐inhibitor concentrate

BACKGROUND: Hereditary angioedema (HAE) due to C1 inhibitor deficiency manifests as recurrent swelling attacks that can be disabling and sometimes fatal. Long‐term prophylaxis with twice‐weekly intravenous injections of plasma‐derived C1‐inhibitor (pdC1‐INH) has been established as an effective trea...

全面介紹

Na minha lista:
書目詳細資料
發表在:Allergy
Main Authors: Zuraw, B. L., Cicardi, M., Longhurst, H. J., Bernstein, J. A., Li, H. H., Magerl, M., Martinez‐Saguer, I., Rehman, S. M. M., Staubach, P., Feuersenger, H., Parasrampuria, R., Sidhu, J., Edelman, J., Craig, T.
格式: Artigo
語言:Inglês
出版: John Wiley and Sons Inc. 2015
主題:
Original Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4755045/
https://ncbi.nlm.nih.gov/pubmed/26016741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/all.12658
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍